Industrial Policy & Trade Monitor· 2667 actions· ✨ 89 recent

On 3 June 2026 the European Commission adopted a legislative proposal for the Cloud and AI Development Act (CADA) — COM(2026) 502 — as part of the European Technological Sovereignty Package. The CADA proposes to triple EU data-centre capacity over five to seven years, introduces a single EU-wide sovereignty assessment framework for cloud and AI services, and establishes common EU-level procurement mechanisms for public administrations prioritising EU-based cloud and AI infrastructure. As a Commission proposal the CADA now enters co-decision (European Parliament + Council) and is not yet law; it is structurally distinct from the co-adopted Chips Act 2.0, addressing cloud infrastructure and AI compute capacity rather than semiconductor supply chains.

The European Commission and the US announced on 24 April 2026 the signing of a Memorandum of Understanding (MoU) on a strategic partnership on critical minerals, accompanied by an EU-US Critical Minerals Action Plan. The framework deepens cooperation on supply-chain security across the strategic raw-materials list shared between the two jurisdictions — joint financing, recycling, mutual recognition of strategic- project status under the EU Critical Raw Materials Act (filed: 2024-05-23-eu-crma-entry-into-force) and US IRA §30D / §45X frameworks (filed: 2022-08-16-us-inflation-reduction-act). The agreement is positioned as a joint response to non-market practices in third-country supply chains for the named materials.

The European Commission approved Germany's €3.8 billion industrial electricity price relief scheme (Industriestrompreis, State Aid Case SA.120495) on 16 April 2026 under Section 5 of the Clean Industrial Deal State Aid Framework (CISAF), covering the period 1 January 2026 to 31 December 2028. The scheme compensates companies in 91 electricity- and trade-intensive sectors for electricity costs above a reference wholesale price floor, subject to a binding conditionality requiring reinvestment of at least 50% of aid in decarbonisation assets within 48 months. The Commission approved the German scheme as part of a coordinated three-Member-State decision also covering parallel Bulgarian and Slovenian electricity price relief schemes, with the combined package totalling approximately €4.22 billion. This is the largest individual CISAF disbursement approved to date, at 11.4× the scale of the parallel Bulgaria SA.120414 scheme (€334m), and establishes the Section-5 upper-bound precedent for EU energy-intensive-industry relief.

The European Commission approved Bulgaria's Electricity Price Relief Scheme (State Aid Case SA.120414) under the Clean Industrial Deal State Aid Framework (CISAF), authorising €334 million for energy-intensive industries over a three-year corridor from 1 July 2025 to 30 June 2028. Aid is delivered via a reduction on beneficiaries' monthly electricity bills through their suppliers, subject to a minimum price floor of €50/MWh. This is the first EU member-state scheme approved under the CISAF framework, establishing the precedential template for subsequent CISAF approvals across the EU industrial base.

On 9 February 2026 the European Investment Fund (EIF), part of the EIB Group, and Deutsche Sparkassen Leasing AG & Co. KG (Deutsche Leasing) signed two InvestEU-backed guarantee agreements — an uncapped EUR 200 million facility and a capped EUR 600 million facility (up to 70% guarantee rate, 5% cap rate on the capped tranche) — totalling up to EUR 800 million. The guarantees let Deutsche Leasing build a portfolio of up to EUR 1.1 billion in new sustainable asset finance, covering an estimated 4,600 leasing and loan contracts (up to EUR 8.25 million each) for SMEs and small mid-caps across its European network. The press release states coverage across 14 European countries but does not name them individually; GTA's own jurisdiction tagging lists all 27 EU member states, which is broader than the "14 countries" figure in the primary source and is not treated as authoritative here.

The European Investment Bank signed a EUR 75 million loan with AMAG Austria Metall AG on 19 December 2025 (publicly announced 23 February 2026), financing research, development, digitalisation and environmental-sustainability upgrades at AMAG's aluminium plant in Ranshofen, Upper Austria. The credit is the first EIB operation in Austria under its new TechEU programme (accelerating industrial innovation in Europe) and benefits from InvestEU programme backing. It contributes to a wider AMAG investment programme with total projected costs of EUR 168 million over 2025-2028, and the EIB explicitly frames the financing as advancing the EU objective of a sustainable, diversified and stable supply of critical raw materials, including aluminium.

The European Commission approved on 15 December 2025 a EUR 408 million Spanish state aid scheme (SA.119880) under the Clean Industrial Deal State Aid Framework (CISAF), funded by the Recovery and Resilience Facility (RRF), to support decarbonisation of manufacturing industry. The scheme funds direct grants — capped at EUR 200 million per company or project — for investments in electrification, switching to renewable or low-carbon hydrogen, waste heat recovery, and carbon capture, storage and utilisation (CCUS) across a wide range of sectors including chemicals, ceramics, paper and metallurgy. Aid is awarded on a first-come, first-served basis to enterprises of all sizes, inside and outside the EU Emissions Trading System, and cannot finance increases in production capacity; Spain expects the scheme to deliver annual emissions savings of around 1.6 megatonnes of CO2, with beneficiary projects required to become operational within 60 months of the aid grant.

In the early hours of 11 December 2025 the Council of the EU and the European Parliament reached provisional political agreement in trilogue on the "EU Pharma Package" — the revised pharmaceutical Regulation (COM 2023/0131) and Directive (COM 2023/0132) — the most significant overhaul of EU pharmaceutical legislation in over two decades. The package replaces Directive 2001/83/EC (Community Code on medicinal products for human use) and Regulation (EC) 726/2004 (the EMA Regulation), and consolidates the orphan-medicine (Regulation 141/2000) and pediatric-medicine regulations into a single framework. Headline provisions: (i) a new "8+1(+1)(+1)" IP-incentive architecture — 8 years of regulatory data protection plus 1 year of market protection, with up to two additional 12-month extensions for products addressing unmet medical need or new active substances meeting comparative-trial conditions, capped at 11 years total; (ii) an EU-wide list of critical medicines under enhanced governance via the Medicines Shortages Steering Group (MSSG) and an EMA "list of critical shortages in the EU"; (iii) mandatory shortage-prevention plans on marketing-authorisation holders for prescription medicines and Commission-designated products; (iv) modernisation of clinical-trial requirements, environmental-risk assessment, antimicrobial stewardship, and a transferable-exclusivity-voucher (TEV) regime to incentivise novel antibiotic R&D. The COREPER I committee endorsed the compromise text on 6 March 2026 and final adoption by Parliament and Council is expected during summer 2026, with the regulatory framework becoming applicable in 2028.

The European Investment Bank (EIB) signed a EUR 250 million financing package with Nexans SA on 31 July 2025 (project reference 20240854, "Nexans Recycling and Electrification Investment"; publicly announced 22 September 2025), against a total project cost of approximately EUR 382 million. The loan backs Nexans' 2024-2029 research, development and innovation programme for high-, medium- and low-voltage power cables, plus copper-recycling and manufacturing-capacity investments across France, Belgium, Sweden and Norway. The financing is structured as a EUR 190 million tranche carrying an InvestEU guarantee and a EUR 60 million second tranche.

The European Commission approved, under EU State aid rules (case SA.118317), a €300 million Slovak scheme to support railway undertakings and rolling-stock owners purchasing new rail freight wagons. Support takes the form of direct grants covering up to 50% of acquisition costs, capped at €200 million per applicant. The Commission assessed the scheme under Article 93 TFEU (transport coordination aid) and found it consistent with the EU's modal-shift goal of moving freight from road to rail.

At the first-ever EU-Central Asia Summit in Samarkand (4 April 2025), the European Commission and Kazakhstan endorsed the EU-Kazakhstan Strategic Partnership Roadmap 2025-2026, operationalising the 7 November 2022 MoU on Sustainable Raw Materials, Batteries, and Renewable Hydrogen with concrete two-year workstreams: geological exploration cooperation, joint R&I programmes (Horizon Europe linkages), skills and training cooperation, and promotion of ESG standards aligned with the EU Critical Raw Materials Act (CRMA, Reg. (EU) 2024/1252). The Roadmap positions Kazakhstan as the EU's primary Central-Asian CRMA Strategic Partner under Art. 37, unlocking a potential multi-billion-EUR Global Gateway financing pipeline and structurally rebalancing KZ critical-mineral export flows away from China/Russia dependencies.

On 25 March 2025 the European Commission adopted the first list of 47 Strategic Projects inside the EU under Article 7 of the Critical Raw Materials Act (Regulation (EU) 2024/1252), followed on 4 June 2025 by 13 Strategic Projects located in third countries — 60 designations in total. The 47 EU projects span 13 Member States and 14 strategic raw materials, with an expected EUR 22.5bn capital-investment envelope; the 13 third-country projects require a further EUR 5.5bn. Designation triggers fast-track permitting (max 27 months for extraction, 15 months for processing/recycling), preferential access to EU/EIB/EBRD finance, and Member State priority status, operationalising the CRMA's 2030 benchmarks (≥10% extraction, ≥40% processing, ≥25% recycling, ≤65% single-country dependence).

On 19 March 2025 the European Commission adopted the European Steel and Metals Action Plan (COM(2025) 122 final, IP/25/805) — the first standalone sector-specific industrial-policy framework for the EU steel and base-metals industries (~2.6m direct + indirect jobs). The Plan bundles six work strands — affordable energy, trade defence and circularity (including announced replacement of the post-30 Jun 2026 steel safeguard with a "highly effective" successor measure and a melt-and-pour origin requirement), lead-market measures (Steel and Metals Industrial Decarbonisation Bank with a EUR 100bn target and a EUR 1bn pilot auction in 2025, "Made in EU" criteria in public and defence procurement), capacity and investment funding, scrap and critical-input circularity (including CBAM extension to downstream steel and aluminium products by end-2025), and skills / just transition.

Regulation (EU) 2024/1735 - the Net Zero Industry Act (NZIA) - was published in the Official Journal on 22 June 2024 and entered into force on 12 July 2024 (twenty days after OJ publication). It sets a binding target that at least 40% of the EU's annual deployment needs for net-zero technologies be manufactured within the EU by 2030. It establishes a streamlined permitting regime for Net-Zero Strategic Projects (NZSP) capped at 18 months for construction permits (9 months for smaller projects), creates Net-Zero Regulatory Sandboxes, and requires public procurers and auction designers to include resilience and sustainability criteria that effectively favour non-China-sourced equipment. The Act is the manufacturing-capacity complement to the Critical Raw Materials Act (CRMA, Reg 2024/1252, filed separately) and was explicitly designed to close the EU's competitive gap with US IRA manufacturing incentives.

The EU Critical Raw Materials Act (Regulation (EU) 2024/1252) entered into force on 23 May 2024 after publication in the EU Official Journal on 3 May 2024. The Act sets binding 2030 benchmarks for the Union: ≥10% of annual consumption from domestic extraction, ≥40% from domestic processing, ≥25% from domestic recycling, and a strict ≤65% concentration limit from any single third country for each strategic raw material. It establishes a list of 17 strategic raw materials and 34 critical raw materials, creates a "Strategic Project" fast-track permitting regime (≤27 months for extraction, ≤15 months for recycling), and mandates joint purchasing and supply-risk stress tests for large EU manufacturers.

Council Regulation (EU) 2022/2372, adopted 24 October 2022, establishes a binding framework empowering HERA (Health Emergency Preparedness and Response Authority) to activate emergency supply measures for crisis-relevant medical countermeasures — vaccines, therapeutics, PPE, medical devices, and in-vitro diagnostics — when a public health emergency at Union level is declared under Regulation (EU) 2022/2371. Emergency-mode powers include joint procurement on behalf of Member States, mandatory information requests to manufacturers on stockpiles and production capacity, accelerated R&D funding under the Emergency Research and Innovation Plan, and Union-level stockpile authority. This is the foundational binding instrument for the EU's post-COVID medical supply-chain resilience architecture; it is referenced by every subsequent EU pharma-resilience initiative including the Critical Medicines Act proposal (2025) and the 2025 MCM Strategy.